RCS - NewMed Energy - Q1 2023 Results

BPAnnouncement

11/05/2023 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230511:nRSK0980Za&default-theme=true

RNS Number : 0980Z  NewMed Energy  11 May 2023

11 May 2023

Against the background of progress towards a BP-ADNOC deal:

NewMed Energy's net profit leaps to some $121 million in Q1/2023 - up approx.
44%

 

 

·   Q1 revenues totaled approx. $281 million versus approx. $247 million in
Q1/2022, up approx. 14%.

·   In Q1/2023, approx. 2.8 BCM were produced from Leviathan.

·   Negotiations continue to advance the tender offer made by energy giants
BP and ADNOC.

·   In Q1/2023, NewMed Energy paid ILS 179 million to the State in
royalties and taxes

·   According to the Partnership's assessments, presented this quarter to
the Knesset's committee supervising Israel's sovereign wealth fund, the
Leviathan reservoir alone is expected to contribute to the State coffers over
the coming decade the sum total of ILS 46 billion

·   Yossi Abu, CEO of NewMed Energy, said: "The project for expansion of
production from Leviathan will enable us to provide more quantities of natural
gas to the local market, while acquiring new export markets through LNG"

 

NewMed Energy has just released its financial statements for the first quarter
of 2023.

 

The net profit in Q1 surged to some $121 million, up approx. 44% from $84
million in Q1/2022. The increase resulted mainly from an increase in revenues
from natural gas sales from the Leviathan reservoir, and a decrease in
depreciation, amortization and depletion expenses.

 

Revenues from the sale of natural gas increased by some 14% to approx. $281
million in this quarter, compared with some $247 million in Q1/2022. Revenues
after deduction of royalties amounted to approx. $240 million, compared with
approx. $211 million in Q1/2022.

 

Production from the Leviathan reservoir increased this quarter to approx. 2.8
BCM of natural gas, supplied to customers in the regional market (Jordan and
Egypt) and in the Israeli market, compared to approx. 2.7 BCM in Q1/2022.

 

As recalled, in March NewMed Energy reported an offer to purchase 50% of the
Partnership's participation units, submitted by energy giants BP and ADNOC,
based on a valuation of ILS 14.1 billion. In the weeks passed since the offer
was made, NewMed Energy's Board of Directors appointed the Audit Committee to
review and decide any issue pertaining to the purchase of the publicly-held
units in the transaction.

 

The committee holds regular meetings to promote the transaction, for which
purpose it has selected economic, financial and legal advisors. Concurrently,
BP and ADNOC are carrying out a due diligence review of NewMed Energy and its
assets.

 

With respect to the Leviathan reservoir, the Partnership has recently reported
the continued Pre-FEED work and various technical, commercial and economic
processes for promotion of the Leviathan expansion and FLNG project, which
will supply LNG from Leviathan to the international markets. As recalled, the
Leviathan partners are in advanced technical design and procurement stages in
the project for the third pipeline from the reservoir to the platform, which
is the first step towards increasing the project's natural gas production
capacity.

 

With regard to Aphrodite reservoir, the partners in the reservoir last week
commenced the A-3 well drilling, which is expected to last approximately three
months and is a significant step towards development of the reservoir. This
appraisal well is intended to confirm the estimates regarding the nature and
size of the reservoir, which is currently 4.4 TCF, and will later serve as a
production well.

 

In the first quarter of 2023, NewMed Energy paid the State ILS 179 million in
royalties and taxes. According to the Partnership's reports and assessments
presented this quarter to the Knesset's special committee supervising Israel's
sovereign wealth fund, the Leviathan reservoir alone is expected to contribute
to the State coffers over the coming decade the sum total of ILS 46 billion.

 

Yossi Abu, CEO of NewMed Energy, said: "The consistently excellent financial
results we demonstrate one quarter after another attest to the success of
Leviathan's regional strategy, alongside our commitment to supply the needs of
the local economy. The project for expansion of production from Leviathan will
enable us to provide more quantities of natural gas to the local market, while
acquiring new export markets through LNG. We are in the midst of a process for
review and promotion of the unprecedented tender offer made by BP and ADNOC,
and I have no doubt we will be able to close the deal".

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAGPUBCAUPWUQG